12-6535556-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002046.7(GAPDH):​c.29+695A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 610,906 control chromosomes in the GnomAD database, including 21,377 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 9272 hom., cov: 32)
Exomes 𝑓: 0.23 ( 12105 hom. )

Consequence

GAPDH
NM_002046.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.149

Publications

11 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.516 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAPDHNM_002046.7 linkc.29+695A>G intron_variant Intron 2 of 8 ENST00000229239.10 NP_002037.2 P04406-1V9HVZ4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAPDHENST00000229239.10 linkc.29+695A>G intron_variant Intron 2 of 8 1 NM_002046.7 ENSP00000229239.5 P04406-1

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48546
AN:
151894
Hom.:
9242
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.522
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.297
Gnomad ASJ
AF:
0.175
Gnomad EAS
AF:
0.487
Gnomad SAS
AF:
0.265
Gnomad FIN
AF:
0.277
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.273
GnomAD4 exome
AF:
0.226
AC:
103657
AN:
458894
Hom.:
12105
AF XY:
0.224
AC XY:
48141
AN XY:
214908
show subpopulations
African (AFR)
AF:
0.531
AC:
4544
AN:
8564
American (AMR)
AF:
0.280
AC:
150
AN:
536
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
490
AN:
2792
East Asian (EAS)
AF:
0.507
AC:
984
AN:
1940
South Asian (SAS)
AF:
0.256
AC:
2345
AN:
9174
European-Finnish (FIN)
AF:
0.244
AC:
43
AN:
176
Middle Eastern (MID)
AF:
0.134
AC:
121
AN:
906
European-Non Finnish (NFE)
AF:
0.217
AC:
91147
AN:
419830
Other (OTH)
AF:
0.256
AC:
3833
AN:
14976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
3890
7779
11669
15558
19448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4374
8748
13122
17496
21870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.320
AC:
48624
AN:
152012
Hom.:
9272
Cov.:
32
AF XY:
0.322
AC XY:
23901
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.522
AC:
21650
AN:
41456
American (AMR)
AF:
0.297
AC:
4539
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
608
AN:
3470
East Asian (EAS)
AF:
0.488
AC:
2524
AN:
5176
South Asian (SAS)
AF:
0.263
AC:
1268
AN:
4824
European-Finnish (FIN)
AF:
0.277
AC:
2924
AN:
10552
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14237
AN:
67948
Other (OTH)
AF:
0.277
AC:
584
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1599
3198
4796
6395
7994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.249
Hom.:
2045
Bravo
AF:
0.331
Asia WGS
AF:
0.429
AC:
1489
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
9.9
DANN
Benign
0.67
PhyloP100
0.15
PromoterAI
-0.026
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060620; hg19: chr12-6644722; API